3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
277
Neoplasms
202
Prostatic Neoplasms
118
Polycystic Ovary Syndrome
114
Colorectal Neoplasms
104
Carcinoma, Hepatocellular
103
Carcinoma, Non-Small-Cell Lung
88
Lung Neoplasms
70
Stomach Neoplasms
62
Precursor Cell Lymphoblastic Leukemia-Lymphoma
60
Pain
59
Neoplasm Metastasis
54
Multiple Myeloma
52
Pancreatic Neoplasms
46
Keratosis, Actinic
46
Pain, Postoperative
43
Head and Neck Neoplasms
43
Leukemia, Myeloid, Acute
40
Leiomyoma
39
Recurrence
38
Liver Neoplasms
38
Colonic Neoplasms
37
Uterine Cervical Neoplasms
35
Lymphoma
35
Brain Neoplasms
34
Infertility
33
Papillomavirus Infections
32
Ovarian Neoplasms
31
Lymphoma, Follicular
31
Lymphoma, Non-Hodgkin
30
Interventions
Sildenafil Citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Interventional
×
Erectile Dysfunction Following Radical Prostatectomy
×
Clear all
NCT06875258
2025-03-13
PEHAB-II
The Netherlands Cancer Institute
Phase 4
Recruiting
198 enrolled